R. Michael Carruthers

R. Michael Carruthers

Former Chief Financial OfficeratEdgewise Therapeutics· In the 2025 proxy

Pay in FY2025Edgewise Therapeutics stock -7.1% the same year

R. Michael Carruthers was paid $2.6M in FY2025 (Dec). Edgewise Therapeutics stock fell 7.1% that year.

Pay$100 in the stock at the end of FY24 → $93
Pay is from the Summary Compensation Table of each Edgewise Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Edgewise TherapeuticsPublic company · 1 yr
    • Former Chief Financial Officer2025 – Present · 1 yrStock in role +37%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?